Bristol Myers ups revenue guidance again, raising confidence in cost-cutting

Bristol Myers Squibb is lifting its 2024 financial guidance for the second straight quarter as CEO Chris Boerner’s “transition period” continues. The company is now forecasting about a 5% increase in revenues this year, up ...